China Kanghui Holdings to Report First Quarter 2012 Financial Results
-- Company to Hold Conference Call on May 25, 2012 at 8:00 am ET --
CHANGZHOU, China, May 8, 2012 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that the Company plans to release first quarter 2012 financial results on Thursday, May 24, 2012, after the market closes.
Kanghui will hold a corresponding conference call and live webcast at 8:00 a.m. ET (8:00 p.m. Beijing Time) on Friday, May 25, 2012 to discuss first quarter 2012 results and answer questions from investors. Listeners may access the call by dialing:
US Toll Free: 1-866-519-4004
US Toll/International: 1-718-354-1231
Hong Kong Toll Free: 800-930-346
Hong Kong Toll: 852-2475-0994
China Toll Free: 800-819-0121
China Toll Free (Mobile): 400-620-8038
Conference ID: 76263126
A replay of the webcast will be accessible through June 1, 2012 on http://ir.kanghui.com or by dialing:
United States toll free: +1-866-214-5335
US Toll/International: +1-718-354-1232
Passcode: 76263126
About China Kanghui Holdings
Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine, and has an extensive nationwide network of distributors for its products in China, as well as in 28 other countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products and product lines, and enhancing existing products and product lines. For more information, please visit www.kanghui.com.
Contact:
China Kanghui Holdings Investor Relations Department
+1-888-321-2558
Asia Bridge Capital Limited
Carene Toh
+86-186 1835 6339
[email protected][email protected]
SOURCE China Kanghui Holdings
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article